Target trial emulation: Do antimicrobials or gastrointestinal nutraceuticals prescribed at first presentation for acute diarrhoea cause a better clinical outcome in dogs under primary veterinary care in the UK?

• Published in: PloS one Vol. 18; no. 10; p. e0291057
• Main Authors: Pegram, Camilla, Diaz-Ordaz, Karla, Brodbelt, Dave C, Chang, Yu-Mei, Tayler, Sarah, Allerton, Fergus, Prisk, Lauren, Church, David B, O'Neill, Dan G
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 04.10.2023; Public Library of Science (PLoS)
• Subjects: Animal species; Animals; Anti-infective agents; Anti-Infective Agents - therapeutic use; Antimicrobial agents; Appetite loss; Big Data; Biology and Life Sciences; Clinical outcomes; Clinical trials; Comorbidity; Complications and side effects; Diarrhea; Diarrhea - drug therapy; Diarrhea - epidemiology; Diarrhea - veterinary; Diet; Dogs; Drug therapy; Epidemiology; Evaluation; Evidence-based medicine; Fever; Functional foods; Functional foods & nutraceuticals; Health aspects; Medical research; Medicine and Health Sciences; Medicine, Experimental; Metronidazole; Patient outcomes; Prescriptions; Primary care; Research and Analysis Methods; Structured Query Language-SQL; United Kingdom - epidemiology; Vomiting; Winter; United Kingdom; United Kingdom > UK
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0291057

Target trial emulation applies design principles from randomised controlled trials to the analysis of observational data for causal inference and is increasingly used within human epidemiology. Veterinary electronic clinical records represent a potentially valuable source of information to estimate real-world causal effects for companion animal species. This study employed the target trial framework to evaluate the usefulness on veterinary observational data. Acute diarrhoea in dogs was used as a clinical exemplar. Inclusion required dogs aged ≥ 3 months and < 10 years, presenting for veterinary primary care with acute diarrhoea during 2019. Treatment strategies were: 1. antimicrobial prescription compared to no antimicrobial prescription and 2. gastrointestinal nutraceutical prescription compared to no gastrointestinal nutraceutical prescription. The primary outcome was clinical resolution (defined as no revisit with ongoing diarrhoea within 30 days from the date of first presentation). Informed from a directed acyclic graph, data on the following covariates were collected: age, breed, bodyweight, insurance status, comorbidities, vomiting, reduced appetite, haematochezia, pyrexia, duration, additional treatment prescription and veterinary group. Inverse probability of treatment weighting was used to balance covariates between the treatment groups for each of the two target trials. The risk difference (RD) of 0.4% (95% CI -4.5% to 5.3%) was non-significant for clinical resolution in dogs treated with antimicrobials compared with dogs not treated with antimicrobials. The risk difference (RD) of 0.3% (95% CI -4.5% to 5.0%) was non-significant for clinical resolution in dogs treated with gastrointestinal nutraceuticals compared with dogs not treated with gastrointestinal nutraceuticals. This study successfully applied the target trial framework to veterinary observational data. The findings show that antimicrobial or gastrointestinal prescription at first presentation of acute diarrhoea in dogs causes no difference in clinical resolution. The findings support the recommendation for veterinary professionals to limit antimicrobial use for acute diarrhoea in dogs.